Presented by Kayla Volis, R&D Microbiologist, RMB and moderated by Ellen Capon, European Pharmaceutical Review
Current rapid sterility methods have been unable to deliver truly rapid sterility results across a large panel of challenge organisms. In this webinar, learn how the Growth Direct® Rapid Sterility (GDRS) System has set out to fulfill the promise of a true rapid sterility testing method across a large, diverse, and challenging organism panel based on the pharmacopeia, industry literature, and global pharmaceutical manufacturers’ challenge panels.
COMPLETE THE FORM TO VIEW THE WEBINAR
By growing the extensive panel of organisms during challenge testing, we demonstrate that GDRS provides rapid results without compromising patient safety. For example, traditional slow-growing organisms, such as C. acnes, were detected in only 56 hours, and a time-to-result was shown to be only 72 hours, highlighting the incredible speed of GDRS.
In this webinar you'll learn:
Who should attend:
Presented by: Kayla Volis - R&D Microbiologist, Rapid Micro Biosystems
Kayla is an R&D Microbiologist for Rapid Micro Biosystems specializing in sterility testing automation. She has successfully assisted in scaling up pharmaceutical manufacturing and supported various continuous improvement projects. Kayla earned a B.S. degree in Biotechnology from Northeastern University.